Volvox carteri and other volvocine green algae comprise an excellent model for investigating developmental complexity and its origins. Here we describe a method for targeted mutagenesis in V. carteri using CRISPR/ Cas9 components expressed from transgenes. We used V. carteri nitrate reductase gene (nitA) regulatory sequences to conditionally express Streptococcus pyogenes Cas9, and V. carteri U6 RNA gene regulatory sequences to constitutively express single-guide RNA (sgRNA) transcripts. Volvox carteri was bombarded with both Cas9 vector and one of several sgRNA vectors programmed to target different test genes (glsA, regA and invA), and transformants were selected for expression of a hygromycin-resistance marker present on the sgRNA vector. Hygromycin-resistant transformants grown with nitrate as sole nitrogen source (inducing for nitA) were tested for Cas9 and sgRNA expression, and for the ability to generate progeny with expected mutant phenotypes. Some transformants of a somatic regenerator (Reg) mutant strain receiving sgRNA plasmid with glsA protospacer sequence yielded progeny (at a rate of~0.01%) with a gonidialess (Gls) phenotype similar to that observed for previously described glsA mutants, and sequencing of the glsA gene in independent mutants revealed short deletions within the targeted region of glsA, indicative of Cas9-directed non-homologous end joining. Similarly, bombardment of a morphologically wild-type strain with the Cas9 plasmid and sgRNA plasmids targeting regA or invA yielded regA and invA mutant transformants/ progeny, respectively (at rates of 0.1-100%). The capacity to make precisely directed frameshift mutations should greatly accelerate the molecular genetic analysis of development in V. carteri, and of developmental novelty in the volvocine algae.
INTRODUCTION
The multicellular green alga Volvox carteri is an exceptional model for investigating developmental mechanisms and the origins of developmental complexity. Volvox carteri possesses just two cell types:~2000 small, terminally differentiated somatic cells embedded within extracellular matrix at the surface of a sphere; and~16 large cells called gonidia that lie just underneath the somatic cell monolayer. Somatic cells provide the spheroid motility and gonidia are specialized for reproduction. The developmental biology of V. carteri is well documented (Kirk, 1998) . In asexual development, each gonidium has the potential to undergo 11-12 rounds of cell division, including both symmetric and asymmetric divisions that generate small somatic and large gonidial precursors. After completion of the cell division phase of embryogenesis, which takes about 6 h, the gonidial precursors lie external to the somatic precursors, which are positioned with presumptive flagellar ends pointing inward toward the center of the embryo, but the embryo inverts to assume the adult configuration. Shortly thereafter the somatic initials differentiate into somatic cells and the gonidial initials begin to mature within the juvenile spheroids. About 36 h after the start of embryogenesis, the juveniles hatch to become young adults, and their gonidia begin producing the next generation when they start cleaving about 12 h later. So, within its brief 48-h life cycle, V. carteri embryos and juveniles execute several fundamental mechanisms typical of plant and/or animal development, including asymmetric cell division, cell repositioning and cytodifferentiation. Volvox carteri is genetically haploid, and numerous mutants affecting these and other developmental traits have been reported (Huskey and Griffin, 1979; Kirk et al., 1987; Miller and Kirk, 1999; Nishii et al., 2003; Ueki and Nishii, 2009) , and some of the affected genes have been cloned and analyzed Miller and Kirk, 1999; Stark et al., 2001; Nishii et al., 2003; Pappas and Miller, 2009; Ueki and Nishii, 2009) .
Interestingly, V. carteri is closely related to less-differentiated unicellular and colonial species and, as is the case for V. carteri, sequenced genomes and genetic transformation methods are available for several of these species, making it feasible to identify in them homologs of key V. carteri genes and to analyze their functions (Schiedlmeier et al., 1994; Merchant et al., 2007; Lerche and Hallmann, 2009 Prochnik et al., 2010; Arakaki et al., 2013; Hanschen et al., 2016; Featherston et al., 2018) . Recently clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 genome editing was developed for unicellular Chlamydomonas reinhardtii (Ren et al., 2014; Baek et al., 2016; Shin et al., 2016; Greiner et al., 2017; Jiang and Weeks, 2017) , greatly facilitating reverse genetic approaches to study the biology of this species. Collectively this family of algal species (the so-called volvocine green algae) comprises a very promising system for the investigation of developmental complexity and multicellularity, and this system would be strengthened by the adaptation of CRISPR/Cas9 technology to other species, most notably V. carteri.
CRISPR/Cas9 genome editing requires two components: Cas9 nuclease and a~100-base single-guide RNA (sgRNA) that consists of a scaffold that binds Cas9 and guides it to a specific 20-base genomic sequence via homology to the 20-base protospacer sequence in the sgRNA. Two main strategies for delivering these components into eukaryotic cells include the so-called DNA-free method, by which Cas9 mRNA/protein and sgRNAs are introduced directly into cells, and a transgene method whereby genes encoding Cas9 protein and sgRNA are transformed into recipient cells to establish lines that express these components. These strategies have reciprocal advantages and disadvantages. The primary advantage of editing by the DNA-free method is that Cas9 is only transiently present, reducing the danger of unintended edits occurring after establishment of edited lines, while the transgene method leaves the Cas9 gene permanently integrated into the genome. On the other hand, the primary advantage of the transgene method over the DNA-free method is that for many research organisms, delivery of components by transformation is generally easier and less expensive than direct delivery, and in fact the most commonly used direct-delivery methods (such as microinjection and electroporation) are not currently available for many organisms, including V. carteri. Therefore, for this study we chose the transgene method for Cas9 and sgRNA delivery.
In transgene-based systems, sgRNA expression is typically driven by a U6 RNA promoter that is recognized by RNA polymerase III. Advantages of the U6 RNA promoter include the facts that RNA polymerase III transcripts are not polyadenylated, and therefore remain in the nucleus, and that U6 RNA gene transcription is very precise with respect to initiation and termination, features that are essential for generation of functional sgRNAs (Paule and White, 2000; Schramm and Hernandez, 2002; Ran et al., 2013) . The sgRNA is designed to target a 20-bp sequence that lies just upstream of a protospacer-adjacent motif (PAM; which is NGG for Streptococcus pyogenes Cas9) and to be co-expressed with Cas9 that has been engineered to contain a nuclear localization signal. Double-stranded breaks generated by Cas9 are usually repaired by an error-prone non-homologous end joining (NHEJ) mechanism that results in insertion/deletion mutations at the site of the break (Hsu et al., 2014) . Alternatively, if a DNA template homologous to both sides of the break is provided, homologydirected repair can be achieved, in which case in principle any sequence can be homologously recombined into the genome (Bibikova et al., 2001 ).
Here we set out to establish CRISPR/Cas9 targeted mutagenesis in V. carteri. Early efforts to perform targeted mutagenesis/genome editing with CRISPR/Cas9 in the related green alga C. reinhardtii were largely unsuccessful, possibly because sustained Cas9 expression is toxic (Jiang et al., 2014) . These attempts involved use of constitutive plant regulatory sequence (Cauliflower Mosaic Virus 35S promoter) to drive Cas9 expression, so to better modulate Cas9 accumulation we generated an expression vector in which the Cas9 coding region is flanked by regulatory sequences from the nitrate-inducible V. carteri nitrate reductase gene (nitA). Because non-selected genes can be co-transformed with selectable marker genes at high frequency (typically > 50%; target expression is in gonidia, which generate easily visible adults about 5 days after transformation) in V. carteri, we generated separate Cas9 and sgRNA vectors so that modification of the protospacer sequence in the sgRNA cassette can be accomplished in a single step. In separate experiments we co-transformed our Cas9 vector with sgRNA vectors that target three different V. carteri genes (glsA, regA and invA) that when mutated give rise to easily detected developmental defects in asymmetric division, somatic cell differentiation and embryo inversion, respectively. In each experiment we recovered mutants, at frequencies that varied for each gene and ranged from < 0.01% to 100%, and in each case the mutants contained indels in the targeted genes precisely where expected based on the protospacer sequence incorporated into the sgRNA vector. These results demonstrate that CRISPR/Cas9 technology can be used to make targeted mutations in V. carteri, which should accelerate reverse genetic analysis of candidate developmental genes in this organism.
RESULTS
Generation of Volvox Cas9 and sgRNA vectors pVcCas9-1 and pVsgRNA-stuffer, and strategy for mutant screen Our attempt to establish a Cas9-based genome editing system for V. carteri began with a modified version of a plant Cas9 vector (pCambia Cas9 + sgRNA) that generated targeted NHEJ mutations in the C. reinhardtii genome but could not be stably maintained in transformed lines (Jiang et al., 2014) . We removed the sgRNA cassette and other extraneous sequences from this vector and replaced the plant regulatory sequences that drive Cas9 expression with nitrate-inducible/ammonia-repressible V. carteri nitA gene regulatory sequences to generate pVcCas9-1 (Figure 1a ). To generate an sgRNA cassette we first identified V. carteri genes homologous to a known C. reinhardtii U6 RNA gene and used~500-bp fragments of DNA upstream and downstream from the predicted transcription start and Figure 1 . Schematic representation of Cas9 and sgRNA gene sequences in pVcCas9 and pVsgRNA-stuffer vectors and putative Volvox carteri U6 genes. (a) pVcCas9-1 is a modified version of pCambia Cas9 + sgRNA (plant Cas9/sgRNA expression vector reported by Jiang et al., 2014) . Cas9 gene sequence in pVcCas9-1 is flanked by nitrate-regulated nitA gene regulatory sequences and contains a 2 9 FLAG epitope tag sequence near the N-terminal coding region and a nuclear localization signal in the C-terminal coding region. In pVcCas9-2, nitA 5 0 regulatory sequence was replaced with a chimeric hsp70A/rbcS3 5 0 regulatory fragment. pVsgRNA-stuffer plasmid contains the following: V. carteri U6 RNA gene 5 0 and 3 0 regulatory sequences; a 'stuffer' region that can be excised by BtgZI digestion and replaced by a 20-bp protospacer sequence; sgRNA scaffold sequence; and a hygromycin-resistance gene cassette for selection ( Figure S1 ). Primer locations used for gPCR and RT-PCR experiments are indicated by small arrows above gene diagrams. Sequence modules not drawn to scale. (b) The five V. carteri genes most similar to a known C. reinhardtii U6 RNA gene (as determined by BLASTN and sequence alignment analyses; Jakab et al., 1997) are shown. Underlined text indicates predicted TATA box beginning 28-bp upstream of the transcription start site (except for U6-4) and italicized text indicates predicted 101-base transcript. All five predicted V. carteri U6 RNA genes shown here are identical throughout the transcribed region. Lowercase text within the transcribed region of C. reinhardtii U6 RNA gene indicates bases that differ from V. carteri transcripts. U6-2a and U6-2b are identical to each other over the regions 500 bp upstream of the predicted transcription start site and 500 bp downstream of the transcription termination site. These regions of U6-2a/U6-2b were used as sgRNA regulatory sequences in the sgRNA cassette.
termination sites of one of them (U6-2a/U6-2b; Figure 1b ) as regulatory sequences that flank the sgRNA protospacer and scaffold. This cassette contains two BtgZI restriction enzyme sites at opposite ends of a 'stuffer' fragment that lies just upstream of the sgRNA scaffold and permits easy insertion of 20-base protospacer sequences to target specific genes (Figure 1a ). This cassette was inserted into a hygromycin resistance plasmid (pVcHyg; Figure S1 ) to generate sgRNA vector pVsgRNA-stuffer. The workflow for transformation of these plasmids into V. carteri and screening of mutants is shown in Figure 2 .
Targeting glsA for mutation with pVcCas9-1
We chose developmental genes as targets to test our Cas9-transgene-based mutagenesis system because their mutant phenotypes are easily screened by inspecting individuals or populations of algae by stereomicroscopy. We attempted to mutate glsA first because the Gonidialess (Gls) phenotype caused by glsA mutations (no or few reproductive cells per spheroid) is readily recognized in the Reg (Somatic Regenerator) genetic background (strain 153-68-BN), and Reg mutants are more easily transformed than the wild-type as they make a much higher ratio of reproductive to somatic cells. We generated two sgRNA vectors, with protospacer sequences identical to 20-bp sequences within the first (pVsg-glsA7) or 12th (pVsg-glsA4) exon (Figure 3a) . A domain of GlsA encoded by DNA downstream of exon 12 is essential for its function in asymmetric division (and production of gonidia), so INDEL mutations at either site should result in the Gls phenotype (Figure 3a; Miller and Kirk, 1999; Cheng et al., 2005; Pappas and Miller, 2009) .
First, we co-bombarded pVcCas9-1 with pVsg-glsA4 (G4) or pVsg-glsA7 (G7) into Reg strain 153-68-BN, and obtained nine and 12 hygromycin-resistant transformants, respectively. All transformants and their progeny were indistinguishable from the recipient strain when cultured in ammonia standard Volvox medium (ASVM). Spheroids from seven G4 and seven G7 transformant lines were cultured in urea-free standard Volvox medium (UFSVM) flasks to induce Cas9 expression. After 6 days of induction (two generations), all the G7 transformant progeny appeared to develop normally with respect to gonidial number, but three of the G4 transformants each gave rise to 5-10 Gls progeny, out of~100 000 examined for each line (Figure 3b) . One Gls spheroid was picked for each transformant line. When propagated in either UFSVM, ASVM or SVM, all three Gls mutants generated progeny with the Gls phenotype, indicating that the phenotype was genetically heritable. Interestingly, these mutants all had a 'tight' Gls phenotype such that nearly every individual produced no gonidia, in contrast with the slightly leaky, 'quasi-Gls' phenotype reported for a glsA mutant that contains a transposon insertion within the 5th intron, which produces 0-4 gonidia per spheroid at roughly equal frequency . For each mutant line, genomic DNA containing the G4 target region was polymerase chain reaction (PCR) amplified and the products were sequenced. Short INDELs including two 2-bp deletions and a 11-bp deletion plus 1-bp insertion were present in the mutant lines ( Figures 3b and S2 ), indicating that Cas9 was translated and active, and had made double-stranded breaks at the site specified by the G4 sgRNA that were subsequently repaired imperfectly following NHEJ.
To determine whether the Cas9 and sgRNA transgenes were present and expressed in the Gls mutants, we performed genomic and reverse transcriptase (RT)-PCR on DNA and RNA, respectively, extracted from individuals cultured in UFSVM (induces Cas9 expression). We detected DNA and RNA corresponding to both transgenes, for all three mutants (Figure 4a and b), indicating that they continued to possess and express both transgenes after the Cas9 mutations had been generated.
Targeting regA and invA for mutation using pVcCas9-1
Next, we tested our Cas9 mutagenesis system on the regA and invA genes, to determine whether it can work on genes other than glsA, and whether it also works in the wild-type background. First, we co-bombarded wild-type strain EVE with pVcCas9-1 and either pVsg-regA1 (R1) or pVsg-regA2 (R2), and we obtained a total of nine independent hygromycin-resistant transformants, six for R1 and three for R2. Surprisingly, four of six transformants from the pVcCas9-1 plus R1 bombardment and one of three from the pVcCas9 plus R2 bombardment were Reg mutants, despite the fact that the bombarded embryos and developing spheroids had been cultured under conditions (ammonia as nitrogen source) that should have repressed Cas9 expression (Figure 3c) . We cultured the two wild-type R2 transformants in UFSVM to induce Cas9 expression and found a single Reg mutant among~100 000 progeny analyzed for each. Genomic DNA spanning the targeted regions in the regA gene of all six Reg mutants was PCR amplified and sequenced, and INDELs were detected within the 20-bp sequences targeted by R1 and R2 in the respective mutants (Figures 3c and S2) , except for the R2 mutant that was obtained after inducing (a) Genomic DNA was extracted from five pVcCas9-1 transformant lines (three from 153-68-BN and two from EVE recipient strains) and polymerase chain reaction (PCR)-amplified with 5 0 UTR and Cas9 gene primers ( Figure 1a ). Products from transformant DNAs (lanes 1-5) had the expected 420-bp fragment that was present in amplified DNA of the positive control template pVcCas9-1 (lane 8) and not present in recipient strain (lane 6) or the no-template control (lane 7). The transformants all gave rise to product, indicating the presence of Cas9 sequence. (b) RNA was isolated from 4 pVcCas9-1 transformant lines and used to prepare cDNAs. The cDNAs were amplified with Cas9 gene primers spanning the intron (Figure 1a) , and the products were electrophoresed. All four transformants gave rise to a product of expected size for the spliced Cas9 transcript (270 bp; lanes 1-4). Products corresponding to genomic DNA/unspliced transcript can also be observed (420 bp) in these transformants and in the positive control template (lane 6). (c) Genomic DNA was extracted from five pVcCas9-1 transformant lines (three from 153-68-BN transformants and two from EVE transformants) and PCR-amplified with sgRNA gene primers (Table S2 ). Most transformant DNAs gave rise to a fragment of expected size (395-bp fragment, the same as for positive control template pVsgRNA, lane 8); the recipient strain (lane 6) and the no-template control (lane 7) produced no product. (d) RNA was prepared from pVcCas9-1 transformant lines (153-68-BN transformants) and used to prepare cDNAs. The cDNAs were PCR amplified using sgRNAspecific primers (Table S2 ). All transformants analyzed gave rise to products of the approximate size expected for the sgRNA transcript (107 bp). (e) RNAs from (d) were used to generate cDNAs and the cDNAs were PCR amplified with Volvox carteri a-1-tubulin gene-specific primers (Table S2) . For each transformant, products of the size expected for spliced tubulin cDNA transcript (122 bp) were obtained, while no products of the size expected for the genomic DNA (246 bp) were detected. For experiments depicted in panels (b) and (d), the reverse transcriptase (RT)-PCR products were cloned and sequenced, and found to correspond to the expected transcript sequence for the Cas9 and sgRNA genes, respectively. Cas9 expression for several generations. We suspect that this mutant arose spontaneously, and its mutation did not result from NHEJ targeted by Cas9.
To determine whether Cas9 and sgRNA expression were sustained in Cas9-directed mutants, we further analyzed the progeny of two R1 Reg mutants (R1-1 and R1-2), after culturing in UFSVM, for the presence of the Cas9 and sgRNA transgenes and for Cas9 transcripts. Interestingly, we could detect the Cas9 and sgRNA genes and the Cas9 transcript in R1-2, but the sgRNA gene could not be amplified from R1-1 genomic DNA (Figure 4a-c) . In aggregate, these results suggest that Cas9 generated double-stranded DNA breaks that resulted in NHEJ mutations in regA, but that in at least one case (for transformant R1-1), at least parts of the sgRNA plasmid were not stably integrated. This result is consistent with the idea that the Cas9 and/or sgRNA genes can be expressed without/prior to integration into the genome.
In a separate experiment, we co-transformed pVcCas9-1 and pVsg-invA3 (I3) into EVE in an attempt to generate mutations in the invA gene. We obtained two hygromycinresistant transformants, both of which were morphologically wild-type. The transformants were cultured in UFSVM to induce Cas9 expression, and one of the transformants yielded several individuals with a partial inversionless phenotype identical to that reported for invA mutants (Nishii et al., 2003) , among the~2000 progeny examined. We sequenced the target region within invA for two of these mutants and found identical 11-bp deletions there (Figures 3d and S2) , suggesting that the mutants might be siblings.
Attempted constitutive expression of Cas9 with pVcCas9-2
In an attempt to improve the efficiency of Cas9-directed mutagenesis for guide RNAs that work relatively inefficiently, we generated a new vector (pVcCas9-2) that uses the hybrid hsp70A-rbcS3 (HSR) gene fragment to drive expression of Cas9 (Figure 1a) . The HSR fragment provides constitutive, high-level expression of genes in V. carteri (Jakobiak et al., 2004) . pVcCas9-2 and guide RNA vector G4 were co-transformed into Reg strain 153-68-BN, and we obtained seven hygromycin-resistant transformants. All pVcCas9-2 + G4 transformants resembled the recipient strain. Even after culturing these transformants in SVM for many generations, we could not detect Gls mutants among their progeny. To determine whether the transformants contained the constitutive Cas9 gene (pVcCas9-2/pVsg transformants), we extracted genomic DNA from four of the independent transformant lines and tested for the presence of the Cas9 gene by PCR. The primers were designed to produce an amplicon that began within the hsp70A/ rbcS3 promoter and terminated within the Cas9 gene of pVcCas9-2 (Figure 1a ; Table S2 ). We obtained PCR products of the expected size, and the sequenced products confirmed that the transformants did contain the Cas9 gene with HSR regulatory sequences. To determine whether the transformants expressed the Cas9 gene, we extracted total RNA from the same four transformant lines and analyzed it by RT-PCR using the same primer set (Figure 1a) . Each transformant gave rise to a product of the size expected for the spliced Cas9 cDNA, indicating that the transformants did express Cas9 ( Figure S3 ).
DISCUSSION
Here we report a transgene-based method for efficient targeted mutagenesis in V. carteri that should complement previously established gene knockdown and gene-tagging tools for systematic genetic analysis of this organism. This method involves two vectors with V. carteri gene regulatory sequences: one vector that contains a nitrate-inducible Cas9 gene; and one that contains a hygromycin resistance selectable marker gene and an sgRNA gene. Creating customized sgRNA vectors requires a single cloning step and two short oligonucleotides that specify the target, making it possible to make mutants quickly and inexpensively. We were able to generate mutations in three different test genes, and in both the wild-type and in a Reg mutant, suggesting that Cas9 mutagenesis of V. carteri should be generalizable to different genes and genetic backgrounds.
Cas9 mutagenesis rates are variable, and mutagenesis sometimes occurs without Cas9 induction
Overall, 11 of 18 hygromycin-resistant transformants that had been co-bombarded with the VcCas9-1 and sgRNA plasmids ultimately generated progeny with the targeted mutant phenotypes. It is likely that some transformation events did not result in mutant progeny because the transformants did not receive a functional sgRNA and/or Cas9 gene, or because the guide RNA was not able to direct Cas9 cleavage of the target site. When guide RNAs were successful at generating mutants, these mutants appeared at very different rates, ranging from < 0.01% to 100%. Presumably the mutagenesis rate for each guide RNA is a function of the identities of nucleotides at specific positions within the guide RNA sequences, and/or of chromatin structure in the targeted region of the gene. Fortunately, as V. carteri is haploid, it reproduces rapidly in its asexual phase, and large populations can be easily screened visually for morphological defects, even mutagenic events at the lower end of this range can be identified relatively easily, if they cause phenotypes that are readily distinguished from the wild-type. Nevertheless, it would be useful to be able to predict guide RNA sequences that lead to higher mutagenesis rates, to expedite mutagenesis.
A result that was particularly surprising to us was that some transformants receiving Cas9 and sgRNA transgenes expressed a mutant phenotype without inducing Cas9 expression by growth in nitrate-containing medium.
Among genes tested here, this phenomenon occurred only for sgRNAs that targeted regA, but this cannot be a regAspecific occurrence, as we subsequently found a different class of mutants to appear without induction of Cas9 expression, following co-bombardment of EVE with pVcCas9-1 and a guide RNA targeting a different gene (data to be reported elsewhere). The nitA promoter is reported to be under very tight repression by ammonia (Gruber et al., 1992) , but it is possible that some Cas9 transcripts are made under repressing conditions and these are enough to produce sufficient Cas9 to make targeted double-stranded breaks, provided its sgRNA partner is very effective. Alternatively, Cas9 transcripts could be produced before the Cas9 gene integrates into the genome and becomes subject to transcriptional controls imposed by chromatin structure. It was also surprising that one Cas9-generated Reg mutant (R1-1) did not contain an intact sgRNA gene (Figure 4c ). This finding was consistent with the interpretation that Cas9 and/or the sgRNA can be expressed prior to integration of the transgenes.
Comparison of Cas9 mutagenesis in Volvox carteri and Chlamydomonas reinhardtii
Both transgene-based and DNA-free CRISPR/Cas9 mutagenesis/editing systems have been reported for the close V. carteri relative C. reinhardtii (Jiang et al., 2014; Baek et al., 2016; Shin et al., 2016; Greiner et al., 2017; Jiang and Weeks, 2017) , and these different systems have produced varying outcomes, with some similarities and some differences compared with those we report here for our V. carteri system. For instance, two reports indicated that expression or overexpression of transgenic S. pyogenes Cas9 (SpCas9) is likely toxic to C. reinhardtii (Jiang et al., 2014; Jiang and Weeks, 2017) , a result that informed our decision to use an inducible Cas9 gene for our V. carteri system. Whereas we could detect both Cas9 and sgRNA transcripts in some of our SpCas9-generated mutant lines and in some of our transgenic lines that contained the Cas9 gene with constitutive hsp70A-rbcS3 regulatory sequences, no intact SpCas9 transgene could be detected in the C. reinhardtii mutants obtained following transformation with an SpCas9 transgene. These results suggest that continuous expression of SpCas9 might not be as toxic to V. carteri as it is to C. reinhardtii. Interestingly, sustained expression of Staphylococcus aureus Cas9 (SaCas9) does not appear to be toxic to C. reinhardtii (Greiner et al., 2017) and was more efficient at generating targeted mutations than SpCas9, suggesting that it might be worthwhile to test different versions of Cas9 in V. carteri, as well.
Another interesting contrast in Cas9 mutagenesis outcomes, comparing V. carteri and C. reinhardtii systems, is that all Cas9-generated mutations we characterized were simple and relatively short INDELS, whereas for some C. reinhardtii Cas9-mutagenesis systems, both DNA-free and transgene-based, most generated mutants contained fragments of transformed plasmid DNA integrated at the Cas9 cut site (Shin et al., 2016; Greiner et al., 2017) . It is unclear why these closely related algae differ with respect to how they repair double-stranded DNA breaks. Finally, it is worth noting that the most efficient reported C. reinhardtii Cas9 system, which employs the heat-inducible C. reinhardtii HSP70A promoter to drive expression of SaCas9, can achieve high mutagenesis rates (~10% of survivors selected for a co-transformed antibiotic resistance marker) that are on the same order of magnitude as our highest rates for V. carteri (~60% of antibiotic-resistant transformants), obtained with one of the regA sgRNAs.
Cas9-generated glsA alleles cause a stronger Gls phenotype than a previously characterized transposon-insertion allele
The glsA gene was originally cloned via an insertion of the transposon Jordan near the splice donor site within the 5th intron of the gene . That insertion allele is the only characterized allele of glsA and causes a quasi-gonidialess phenotype such that a reduced number of asymmetric divisions occur during embryogenesis (compared with the wild-type) and progeny spheroids contain zero-four gonidia, instead of~16. Because no glsA transcripts could be detected in this glsA mutant, it was concluded that it contained a null allele, and that glsA is not completely essential for asymmetric division and the production of gonidia. However, the Cas9-derived glsA mutants we generated in this study have a tight Gls phenotype such that they do not produce any gonidia, demonstrating that the Jordan-insertion mutation must not cause complete loss of function, and that glsA is indeed essential for asymmetric cell division.
Future improvements and applications
The CRISPR/Cas9 system that we report here is robust and made it easy to generate mutants in targeted test genes. However, it is likely that in many/most cases the mutant phenotype associated with a targeted gene will be unknown, making it challenging and time consuming to find and test putative mutants when they appear with low frequency, as they did for glsA and invA. Therefore, it would be advantageous to improve the current system to make mutagenesis and identification of Cas9-generated mutants more efficient. One modification that might enhance the mutation rate is to replace the nitA regulatory sequences in the Cas9 vector with hsp70A regulatory sequences, and to apply a heat-shock (or cultivation at elevated temperature) just prior to and/or following transformation. hsp70A regulatory sequences should be able to drive very high levels of expression for a short period of time (Cheng et al., 2006) ; recently a similar approach was shown to be effective for an SaCas9-transgene system in C. reinhardtii (Greiner et al., 2017) . Increasing the expression of Cas9 in this way might improve mutagenesis rates for lower-efficiency sgRNAs, making it easier to find good mutant candidates while reducing the number of sgRNAs that need to be tested for each gene. Because the Cas9 gene in pVcCas9-1 is biased for C. reinhardtii codon usage, which is significantly different from that of V. carteri (~64% versus 55%; Merchant et al., 2007; Prochnik et al., 2010) , Cas9 expression might also be improved by optimizing Cas9 gene codon bias for use in V. carteri. These and/or other modifications that involve improving transient expression of Cas9 could be coupled with a high-resolution melt-based assay to detect mutations within genomic DNAs isolated from pools of transformants or transformant progeny. Mutants could subsequently be identified from within the appropriate pools.
Another strategy that could improve the efficiency of mutant identification is to couple mutation of the targeted gene with reversion of a frameshifted-selectable marker gene, as has been done previously in C. reinhardtii (Jiang and Weeks, 2017) . The idea is to incorporate into a selectable marker gene (such as an antibiotic resistance gene) the same 20-bp protospacer sequence targeted in the gene of interest (GOI), and to transform Cas9 and sgRNA genes into a recipient strain that contains this frameshifted antibiotic resistance gene. If the sgRNA works, some of the transformants that receive the Cas9 and sgRNA genes should contain a repaired antibiotic resistance gene, and GOI mutants should be present among the subset of transformants that are antibiotic resistant.
It might also be worthwhile to test other CRISPR endonucleases, such as Cpf1. Recently Cpf1 was shown to work in C. reinhardtii and to provide very efficient gene editing via homologous recombination (Ferenczi et al., 2017) . Along these lines, homologous recombination and precise genome editing were also achieved in C. reinhardtii via transgene expression of SpCas9 and a co-transformed small (80-mer) oligonucleotide with phosphorothioate-protected ends. A similar strategy might work in V. carteri, and it might also be possible to use homologous recombination to make fluorescence protein and epitope tag knock-ins at endogenous gene locations.
We developed this Cas9 mutagenesis method to facilitate investigations into V. carteri development and the evolution of developmental novelty in the volvocine green algae, and this system should help accomplish that goal. Previous studies have revealed several genes responsible for some of the developmental complexity that has arisen in this family, and other studies have produced an impressive number of candidate genes that might also have played important roles (Duncan et al., 2007; Ferris et al., 2010; Prochnik et al., 2010; Arakaki et al., 2013; Klein et al., 2017; Matt and Umen, 2018) . The complexity of traits under investigation by the volvocine algal research community include, but are not limited to, cell differentiation, cell division number modulation, embryo morphogenesis, cell wall/extracellular matrix architecture and deconstruction, and gametogenesis. It should now be possible to do rapid functional analysis of genes that are strong candidates to contribute to these traits based on their expression patterns or homology to known regulators of these traits. It should also be possible to modify this Cas9 system to interrogate gene function in other species of Volvox and/or colonial volvocine algae, to gain a better understanding of how and when gene functions may have evolved in this family. Stable genetic transformation methods have already been developed for some of these species (Lerche and Hallmann, 2009 , making this goal very achievable.
The volvocine algae have long been a promising model system for exploring the molecular genetic origins of multicellularity. Recent years have seen some of that promise realized with the application of various genetic, genomic and transcriptomic tools to key aspects of volvocine algal biology. With Cas9 mutagenesis a reality, progress toward a deeper understanding of how multicellularity came to be in the volvocine lineage should be close at hand.
EXPERIMENTAL PROCEDURES Strains and media
Volvox carteri strain EVE was as previously described by Kirk et al. (1999) and Miller et al. (1993) , and 153-68-BN was generated by cotransforming 153-68 with the blasticidin resistance vector pVcBlast (Ortega-Escalante et al., 2018) and nitrate-reductase-gene (nitA) vector pVcNR15 (Gruber et al., 1996) . Culture media (SVM and UFSVM) and growth conditions were as previously described by Kirk et al. (1999) and Miller et al. (1993) , with modifications as described below. ASVM is identical to SVM, except that ASVM contains no Ca(NO 3 ) 2 or urea, but instead contains NH 4 Cl (at 1 mM) as the sole nitrogen source and CaCl 2 (0.5 mM) as the calcium source. Cas9 expression was induced in transformant spheroids by transferring them from ASVM to UFSVM after first washing in UFSVM, as described previously (Miller et al., 1993) .
Plasmid construction
Arabidopsis thaliana Cas9 expression vector pCambia Cas9 + sgRNA (kindly provided by D. Weeks) was the source of the C. reinhardtii codon-optimized Cas9 coding sequence (described in Jiang et al., 2013) used to generate the V. carteri-specific Cas9 vectors described in this report, which were constructed as follows. An 1171-bp DNA fragment was gene synthesized (Genscript, Piscataway, NJ, USA) to contain the 999 bp of sequence immediately upstream of the V. carteri nitA start codon, followed by a start codon and four additional codons designed to contain consensus V. carteri splice junction exon sequences (Wolfgang Mages, personal communication) , interrupted between the second and third codons by the first intron of the C. reinhardtii RBCS2 gene, all flanked by 5 0 SmaI and 3 0 SpeI restriction sites. The pUC57-based plasmid provided by Genscript was digested with SmaI and SpeI, as was pCambia Cas9 + sgRNA, and the resulting 1171-bp and 13.1-kb fragments, respectively, were ligated to generate an intermediate vector. This vector was digested with BamHI and KpnI to remove the plant Tnos 3 0 UTR and sgRNA cassette present just downstream of the Cas9 coding region, and it was replaced with an 1812-bp gene-synthesis fragment (Genscript) flanked with BamHI and KpnI sites that contains the following features, in order: (i) the 726-bp nitA 3 0 UTR region (flanked by BamHI and NcoI+XbaI restriction sites); (ii) an sgRNA cassette containing 500 bp of sequence immediately upstream of the predicted transcription start site of a putative V. carteri U6 RNA gene (described in the next section); (iii) sgRNA sequence consisting of a 20-bp protospacer targeting the glsA gene (Table S1) To facilitate the rapid construction of sgRNA vectors that target other genes, we performed the following manipulations. First, pVcCas9 was digested with XbaI, blunted with Klenow, then digested with KpnI to liberate a 1.1-kb fragment containing the sgRNA cassette. This fragment was subcloned into hygromycinresistance vector pVcHyg (Ortega-Escalante et al., 2018) that was digested with BamHI, blunted with Klenow, then digested with KpnI. Next, a 646-bp DNA fragment was gene synthesized to be identical to the sequence from the unique NsiI site 40 bp upstream of the sgRNA transcription start site through the KpnI site just downstream of the sgRNA 3 0 UTR, except that the 20-bp protospacer sequence was replaced by a 58-bp 'stuffer' region containing two BtgZI restriction sites in opposite orientation to each other and each 10 bp from the end of the stuffer region, and with an EcoRI site between them. New plasmid pVsgRNA-stuffer was generated by replacing the NsiIKpnI fragment from the modified version of pVcHyg described above with this NsiI-KpnI fragment. Because BtgZI is a type II S restriction enzyme and there are no other BtgZI sites in pVsgRNA stuffer, new sgRNA vectors that target V. carteri genes can be generated by digesting pVsgRNA stuffer with BtgZI and ligating annealed 24-base oligonucleotides that create 20-base protospacer sequences just upstream of the sgRNA scaffold. New pVsgRNA plasmids targeting specific genes were named accordingly.
pVcCas9 was modified to generate a smaller plasmid (pVcCas9-1) that lacks the sgRNA cassette and other sequences not necessary for Cas9 expression or function, as follows. pVcCas9 was digested with XbaI and BstZ171, and the resulting~9.7-kb fragment was blunted by Klenow reaction and re-ligated to produce pVcCas9-1. Additionally, another Cas9 expression vector containing a constitutive promoter was constructed (pVcCas9-2). A 1259-bp DNA fragment was gene synthesized (Synbio Technologies, Monmouth Junction, NJ, USA) to contain a 783-bp chimeric hsp70A/rbcS3 promoter (Jakobiak et al., 2004) upstream of the start codon plus the same 459 bp present in pVcCas9-1 from start codon through RBCS2 intron and the two codons after it. The fragment was flanked by SmaI and SbfI restriction sites. pVcCas9-1 was digested with SmaI and SbfI, and the resulting~8.2-kb fragment was ligated with the~1.3-kb-digested synthesized fragment to produce plasmid pVcCas9-2.
sgRNA vectors targeting glsA, regA and invA were constructed as follows. The Cas-Designer tool at CRISPR RGEN Tools (http:// www.rgenome.net/cas-designer/; Park et al., 2015) was used to select gene target sequences (Table S1 ); generally targets with ≥ 55% GC content, out-of-frame score ≥ 66, no mismatches to sgRNA, and no potential off-targets with zero, one or two mismatches were chosen. Oligonucleotides were designed to be complementary to each other for the 20 bases of the targeted sequence (to create the protospacer sequence; Table S1 ) and with 4-base extensions at their 5 0 ends to create BtgZI overhangs complementary to those created by BtgZI digestion of pVsgRNA-stuffer. Twenty microliters of each oligonucleotide at a concentration of 40 pM was combined with 10 ll PEI buffer (100 mM MgCl 2 , 500 mM NaCl, 200 mM Tris, pH 7.5) and annealed by heating in a Biorad T100 thermal cycler for 10 min at 95°C, then cooling to 25°C at a rate of 1°C per 40 sec. Annealed oligonucleotides were diluted 1:24 with H 2 O, and 1 ll of this dilution was ligated with 25 ng BtgZI-digested pVsgRNA-stuffer to generate the targeting vectors. To confirm successful annealing, ligation products were sequenced with sgRNA reverse primer (5 0 -GACGAAACCGCA-TAAGCAAC-3 0 ; Table S2 ).
Identification of putative Volvox carteri U6 RNA genes
To identify a V. carteri U6 RNA gene from which regulatory sequences could be used to drive expression of sgRNAs, we conducted a nucleotide BLAST (Basic Local Alignment Search Tool; Altschul et al., 1990 ) using a previously reported C. reinhardtii U6 RNA gene transcript as query (chromosome 8: 3788081-3789192; Jakab et al., 1997) . The parameters were optimized for short sequences, aligned to the V. carteri genome. Sequences immediately upstream of the predicted transcription start site and downstream of the predicted transcription termination site of the putative U6 RNA gene were used to drive expression of sgRNAs.
Biolistic transformation of Volvox carteri
Volvox carteri strains EVE and 153-68-BN were used as recipients for Cas9 and sgRNA plasmids. Plasmids were mixed with gold and used to bombard cells according to the Seashell TechnologyTM (San Diego, CA, USA) protocol described for transformation using the Helios gene gun (EVE transformations; Model PDS-1000/He, Bio-Rad Laboratories, Hercules, CA, USA) and according to a previously described protocol for custom gene gun transformations (153-68-BN transformations; Schiedlmeier et al., 1994) . For EVE, cultures were synchronized, and spheroids were collected using a magnetic filter funnel fitted with a 30-lm nitex mesh filter (Sefar, Heiden, Switzerland). Gonidia and embryos were harvested by disrupting spheroids with a 50-ml dounce homogenizer using a loose-fitting pestle (B. Braun, Melsugen, Germany) and centrifuged at 500 rpm (100 g) for 4 min (Eppendorf centrifuge 5702, brake off) after adding percoll (Sigma; St Louis, MO, USA) to a final concentration of 7%. Pelleted gonidia/embryos were resuspended in ASVM and centrifuged again at 300 rpm (60 g). Pellets were resuspended to a final density of~0.5-1 9 10 5 embryos per shot. For 153-68-BN, whole spheroids were harvested by filtration as described above, then resuspended in fresh medium to a density of~7-8 9 10 6 cells per shot. If necessary, gonidia/embryos were centrifuged and resuspended in ASVM as previously described. In both cases, harvested material was pipetted onto sterile Whatman filter circles (GE Healthcare, Laurel, MD, USA), then bombarded with 10-20 ll of a suspension containing~1 lg of each plasmid precipitated onto gold particles resuspended in 100% ethanol. Unbombarded cells served as negative control. For co-transformation experiments, a Cas9 vector was mixed in equal mass amounts (1 lg each plasmid) with a vector that contains the Streptomyces hygroscopicus AphVII gene (pVcHyg or pVsgRNA plasmids), which confers hygromycin resistance by phosphorylating this aminoglycoside antibiotic. After transformation, bombarded cells were quickly transferred to tubes with 25 ml of ASVM, and those tubes incubated for 2 days at 32°C with 16 h:8 h light-dark regimen. After recovery, hygromycin B was added to each tube to a final concentration of 10 lg ml
À1
, and the contents were mixed. The contents of each tube were then distributed into wells of micro-titer plates, and additional medium containing 10 lg ml À1 of hygromycin was added. Plates were incubated at 32°C until resistant colonies could be isolated and transferred to ASVM containing the same concentration of antibiotic for a second round of selection.
DNA methods
Volvox carteri DNA for genomic PCR was extracted using a method previously reported for isolation of genomic DNA from C. reinhardtii cells (Newman et al., 1990; Dejtisakdi and Miller, 2016) , with the following modifications. Volvox carteri spheroids were grown in SVM to near saturation, then a small amount was transferred to 1.5-ml microfuge tubes, pelleted at 13 000 g for 3 min (to produce a pellet of~200 ll), then resuspended in 500 ll of TEN buffer (10 mM TrisHCl, 10 mM EDTA, 150 mM NaCl) by vortexing, and centrifuged at 13 000 g for 10 sec. The supernatant was discarded, and the pellet was resuspended in 150 ll of water on ice. Three-hundred microliters of sodium dodecyl sulfate (SDS)-SB buffer (2% SDS, 400 mM NaCl, 40 mM EDTA, 100 mM Tris-HCl, pH 8.0) was added and the suspension vortexed to mix. The sample was first extracted with 350 ll of saturated phenol:chloroform:isoamyl alcohol (25:24:1, v:v:v) by vortexing for 5 min at room temperature, then centrifuging at 13 000 g for 5 min before transferring the top aqueous phase into a new 1.5-ml microcentrifuge tube. A second extraction was performed by adding 300 ll chloroform:isoamyl alcohol (24:1, v:v), then following the same steps as for the first extraction. Genomic DNA was precipitated by adding two volumes of 95% cold ethanol at À20°C for 30 min and pelleted by centrifugation at 13 000 g for 10 min, washed with 70% cold ethanol, dried and resuspended in 40 ll of water, treated with 2.5 ll of 10 mg ml À1 RNase and stored at À20°C. To test for the presence of the Cas9 gene in genomic preps, PCRs were conducted on the gDNA from transformants as follows. The 50-ll PCR contained 1 ll of the extracted genomic DNA (or a 1/10 dilution) and the primers cas9-rbcs-F (or HSR-F-set1) and cas9-rbcs-R (Figures 1a and S3 ; Table S2 ), with the following thermal cycler parameters: 95°C for 2 min, followed by 30 cycles of 95°C for 30 sec, 50°C for 30 sec and 72°C for 45 sec, with a final extension at 72°C for 10 min.
To detect INDELs within target sites, PCRs were conducted on the gDNA as previously described. Primers spanning regions for glsA, regA and invA targets were used to detect insertions and/or deletions in the targeted region (Table S3) .
RNA methods
RNA was extracted by centrifuging spheroids from a 300-ml culture at 200 g for 5 min, transferring the loose pellet (~200 ll) to 1.5-ml microfuge tubes, and resuspending in 1 ml of TRI-zol (Molecular Research Center, Inc., Cincinnati, OH, USA). Cells were disrupted with a bead beater system twice for 25 sec using level six (Thermo Savant BIO101-FastPrepâ FP120 Cell Disruptor; Thermo Fisher Scientific, Waltham, MA, USA). The mixture was incubated for 5 min at room temperature, then 200 ll of chloroform was added, and the samples were shaken then put on ice for 3 min. Samples were then centrifuged for 15 min at 12 000 g at 4°C, and the supernatant was transferred to new tubes and precipitated overnight by adding 500 ll of isopropanol and incubating at À20°C. The precipitated RNA was centrifuged at 12 000 g for 10 min at 4°C and supernatant removed. One milliliter of cold 70% ethanol was added for wash and the samples were centrifuged at 7500 g for 5 min at 4°C. The supernatant was removed, and the pellets were air-dried for~10 min then resuspended in 200 ll of RNAse-free water (Thermo Fisher Scientific). A Nanodrop 1000 (ND-1000, NanoDrop Technologies LLC, Wilmington, DE, USA) was used to measure RNA concentration and aliquots were stored at À80°C. Two-five micrograms of each RNA sample was treated with two units of RNAse-free DNAse following the manufacturer's protocol (Ambion Turbo DNA-Free Kit, Life Technologies Corp., Carlsbad, CA, USA), and cDNA was generated by standard methods using random hexamer primers (or sgRNA-specific primers; Table S2 ) from the iScript Select cDNA Synthesis kit (Bio-Rad Laboratories). RT reaction mixes were incubated at 25°C for 5 min, then 42°C for 30 min, then inactivated at 85°C for 5 min. The resulting cDNA samples were used to analyze Cas9 and sgRNA transcripts, using tubulin transcript amplification as a control for the latter. One microliter of the resultant cDNAs was used in 50-ll PCR with conditions as follows: 95°C for 5 min, followed by 30 cycles of 95°C for 30 sec, 58°C for 30 sec and 72°C for 45 sec, with a final extension at 72°C for 5 min. The primers listed in Table S2 were used for RT-PCR reactions (Figures 1a and S3 ).
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